A new drug for ovarian cancer, developed by researchers at the ̽»¨Ö±²¥ of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. ̽»¨Ö±²¥drug, Lynparza, has been granted Marketing Authorisation from the European Commission.
Launched today (26 September), Cancer Core Europe brings together six cancer centres – including the Cambridge Cancer Centre at the ̽»¨Ö±²¥ of Cambridge – to link cancer research through to cancer care.
In a talk on 17 February, Margaret Carlyle, a researcher in the Department of History and Philosophy of Science, will explore the fascinating (often gruesome) development in 18th-century Paris of anatomical models and introduce her audience to a remarkable woman who made her name in a field dominated by men.
A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a clinical trial.
From the elixirs of legend to transmutation of base metals into gold, medieval medical practice and social mobility were steeped in alchemy.
A mechanism regulating our sensation of cold has been identified.
A new study into the grim and frequently heart-breaking history of childhood sickness and death has opened a window on to a surprisingly tender world of close families and devoted parenting in early modern England.
A new Regius Professor of Physic at the ̽»¨Ö±²¥ of Cambridge has been approved by Her Majesty ̽»¨Ö±²¥Queen to succeed Professor Sir Patrick Sissons who will retire on 30 September 2012.
An ancient Incan toothache remedy – for centuries handed down among an indigenous people in the rainforests of Peru – could be on the cusp of revolutionising worldwide dental practice.
Dr Hannah Newton, an historian of science with an interest in how previous generations coped with childhood illness, digs up some 17th century tips for making medicine taste better and finds evidence for common sense and compassion among the doctors of the day.
© 2025 ̽»¨Ö±²¥ of Cambridge